SCHEMBL301967

SCHEMBL301967

N#CC1CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1154203 1.00
SCHEMBL28317862 1.00 DPP4 (0.36)
SCHEMBL2212664 1.00
Hydrochloric Acid SCHEMBL1051598 0.97
Hydrochloric Acid SCHEMBL1188615 0.97
Hydrochloric Acid SCHEMBL6427955 0.97
Hydrochloric Acid SCHEMBL5752608 0.97 DPP4 (0.35)
Hydrochloric Acid SCHEMBL1952975 0.97
Ethane SCHEMBL6181539 0.95
SCHEMBL4824916 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1510 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4147053-B1 ANTXR1 AS A BIOMARKER OF IMMUNOSUPPRESSIVE FIBROBLAST POPULATIONS AND ITS USE FOR PREDICTING RESPONSE TO IMMUNOTHERAPY INST CURIE (FR) 2026-01-28 EP claimed
WO-2025118255-A1 RADIOLABELED FAPI COMPLEX, PREPARATION METHOD THEREFOR, AND USE THEREOF 北京师范大学 2025-06-12 WO claimed
EP-4055014-B1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORP (KR) 2025-04-30 EP claimed
US-12208088-B2 Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof GENENTECH, INC. (US) 2025-01-28 US claimed
EP-3697410-B1 BENZIMIDAZOLE DERIVATIVES AND THEIR USES TEIJIN PHARMA LTD (JP) 2024-12-18 EP claimed
CN-118974055-A Quinazoline compounds as inhibitors of mutant KRAS proteins and uses thereof 美国安进公司 2024-11-15 CN claimed
EP-3023095-B2 DIRECT COMPRESSION FORMULATION AND PROCESS NOVARTIS AG (CH) 2023-11-08 EP claimed
US-20230258645-A1 ANTXR1 AS A BIOMARKER OF IMMUNOSUPPRESSIVE FIBROBLAST POPULATIONS AND ITS USE FOR PREDICTING RESPONSE TO IMMUNOTHERAPY INSTITUT CURIE (FR) 2023-08-17 US claimed
US-11655235-B2 Pyrrolidine and piperidine compounds YUHAN CORPORATION (KR) 2023-05-23 US claimed
EP-4147053-A1 ANTXR1 AS A BIOMARKER OF IMMUNOSUPPRESSIVE FIBROBLAST POPULATIONS AND ITS USE FOR PREDICTING RESPONSE TO IMMUNOTHERAPY Institut Curie (FR) 2023-03-15 EP claimed
CN-1092193-C prolyl endopeptidase inhibitors CHINOIN GYOGYSZER ES VEGYESZET (HU) 2002-10-09 CN claimed
WO-2002053169-A2 USE OF DIPEPTYLPEPTIDASE IV AND AMINOPEPTIDASE-N INHIBITORS IN THE TREATMENT OF ISCHAEMIA-INDUCED NEURO-DEGENERATION KEYNEUROTEK AG I.G. (DE) 2002-07-11 WO claimed
WO-2002053170-A2 COMBINED USE OF ENZYME INHIBITORS AND PHARMACEUTICAL PREPARATIONS THEREOF FOR THE TREATMENT AND PROPHYLAXIS OF ARTERIOSCLEROSIS, FOR THE TREATMENT AND PREVENTION OF ALLERGIC REACTIONS OF TYPE I ACCORDING TO THE GELL AND COOMBS CLASSIFICATION, AND FOR THE TREATMENT AND PREVENTION OF DERMATOLOGICAL DISEASES ASSOCIATED WITH FO INSTITUT FÜR MEDIZINTECHNOLOGIE MAGDEBURG GMBH (IMTM) (DE) 2002-07-11 WO claimed
WO-2001089569-A1 COMBINATIONS OF ENZYME INHIBITOR-CONTAINING PREPARATIONS AND THE USE THEREOF INSTITUT FÜR MEDIZINTECHNOLOGIE MAGDEBURG GMBH IMTM (DE) 2001-11-29 WO claimed
US-6191161-B1 NERVOUS SYSTEM DISORDERS CHINOIN GYOGYSZER ES VEGYESZETI (HU) 2001-02-20 US claimed
CN-1196728-A Prolylendopeptidase inhibitors CHINOIN GYOGYSZER ES VEGYESZET (HU) 1998-10-21 CN claimed
EP-0861246-A1 PROLYLENDOPEPTIDASE INHIBITORS CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. (HU) 1998-09-02 EP claimed
WO-1998035960-A1 PROLYLENDOPEPTIDASE INHIBITORS Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. (HU) 1998-08-20 WO claimed
WO-1997007116-A1 PROLYLENDOPEPTIDASE INHIBITORS CHINOIN GYÓGYSZER ÉS VEGYÉSZETI (HU) 1997-02-27 WO claimed
US-4925901-A STORAGE STAABILITY, ONIUM ION CATALYST THE DOW CHEMICAL COMPANY (US) 1990-05-15 US claimed